Joined Today: 16

ISRY ISORAY, Stock Message Board

All Messages

ISRY Message Board Home | Join The ISRY Group |

#26: ISRY News IsoRay, Inc. Announces Completion of Warrant Call
NewsBot	March 28, 2007 06:00:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. (“IsoRay”) (OTCBB:ISRY), the medical technology company focusing on innovative treatments for solid cancer tumors using its... view message ignore post recommend post

#25: ISRY News IsoRay, Inc. Announces Major Public Financing
NewsBot	March 23, 2007 06:04:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. (“IsoRay”) (OTCBB:ISRY), the medical technology company focusing on innovative treatments for solid cancer tumors using its... view message ignore post recommend post

#24: ISRY News IsoRay Announces Second Quarter 2007 Results and Call of Warrants
NewsBot	February 21, 2007 05:55:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. ("IsoRay") (OTCBB:ISRY), a medical isotope company focusing on brachytherapy solutions for prostate and other malignant tissue cancers... view message ignore post recommend post

#23: ISRY News IsoRay Medical Significantly Increases Site Licensing Pipeline of Cesium-131 from First to Second Fiscal Quarter 2007
NewsBot	January 17, 2007 06:04:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--Spurred by broadening medical center acceptance of Cesium-131 as a brachytherapy treatment for prostate cancer, IsoRay Medical, Inc., from fiscal 1st... view message ignore post recommend post

#22: ISRY News IsoRay Announces Effectiveness of Registration Statement Relating to 9,064,890 Shares of Common Stock
NewsBot	December 4, 2006 06:03:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. (“IsoRay”) (OTCBB:ISRY), a medical technology company focusing on innovative treatment for prostate cancer and other solid... view message ignore post recommend post

#21: ISRY News IsoRay Medical, Inc. Engages Catalyst Financial Resources
NewsBot	November 29, 2006 07:01:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay Medical, Inc. (OTCBB:ISRY), has selected Catalyst Financial Resources, headed up by Marc Robins, CFA, to execute a comprehensive investor... view message ignore post recommend post

#20: ISRY News IsoRay Announces First Quarter 2007 Results and Projected Second Quarter 2007 Sales Revenues
NewsBot	November 15, 2006 06:23:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. ("IsoRay") (OTCBB:ISRY), a medical isotope company focusing on brachytherapy solutions for prostate and other malignant tissue cancers... view message ignore post recommend post

#19: ISRY News Chicago Prostate Cancer Center First in World to Reach 100 Patient Implants Using Cesium-131(TM), Isotope From IsoRay Medical, Inc.
NewsBot	October 17, 2006 07:44:00 AM
CHICAGO--(BUSINESS WIRE)--Chicago Prostate Cancer Center (CPCC) reached a major milestone in prostate brachytherapy (radioactive seed implantation) October 4, 2006, becoming the... view message ignore post recommend post

#18: ISRY News IsoRay Announces Appointment of New CFO, Intent to File for a Listing on AMEX and Increase in Seed Price
NewsBot	September 11, 2006 02:27:00 PM
RICHLAND, Wash.--(BUSINESS WIRE)--Sept. 11, 2006--IsoRay, Inc. ("IsoRay") (OTCBB: ISRY), a medical isotope company focusing on brachytherapy solutions for prostate and other malignant tissue... view message ignore post recommend post

#17: ISRY News IsoRay Announces Preliminary Fiscal Year 2006 Results and Projected First Quarter 2007 Sales Revenues
NewsBot	September 6, 2006 06:00:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--Sept. 6, 2006--IsoRay, Inc. ("IsoRay") (OTCBB:ISRY), a medical isotope company focusing on brachytherapy solutions for prostate and other malignant tissue cancers... view message ignore post recommend post

#16: ISRY News IsoRay Inc. to Present at Roth Capital Conference in New York on September 7
NewsBot	August 31, 2006 11:58:00 AM
NEW YORK--(BUSINESS WIRE)--Aug. 31, 2006--IsoRay Inc, ("IsoRay") (OTCBB:ISRY), a medical technology company focusing on innovative treatment for prostate and other soft tissue cancer tumors through... view message ignore post recommend post

#15: ISRY News IsoRay Announces 1st Round of Institutional Financing Led by MicroCapital LLC; Raising over $5 Million
NewsBot	August 18, 2006 05:58:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--Aug. 18, 2006--IsoRay, Inc. ("IsoRay") (OTCBB:ISRY), a medical technology company focusing on innovative treatments of solid cancer tumors through use of its... view message ignore post recommend post

#14: ISRY News Cesium-131 Radioactive Isotope Seed From IsoRay Medical Spotlighted at 48th Annual AAPM Meeting; Breakthrough Offers Aggressive New Option for Treatment of Prostate Cancer
NewsBot	July 28, 2006 06:35:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--July 28, 2006-- FDA-Cleared Medical Isotope for Prostate and Other Malignant Cancers A powerful new medical isotope -- Cesium 131(TM) -- is providing... view message ignore post recommend post

#13: ISRY News IsoRay Medical, Inc.'s Cesium-131 Cancer Therapy Technology Receives R&D100 Award
NewsBot	July 10, 2006 06:04:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--July 10, 2006--IsoRay Medical, Inc.'s (OTCBB:ISRY) patented Cesium-131 brachytherapy seed (TM) technology has been named one of the year's 100 most technologically... view message ignore post recommend post

#12: ISRY News IsoRay Announces Withdrawal of NASDAQ Application
NewsBot	July 7, 2006 06:45:00 AM
RICHLAND, Wash.--(BUSINESS WIRE)--July 7, 2006--IsoRay, Inc. ("IsoRay") (OTCBB:ISRY), a medical technology company focusing on innovative treatment for prostate cancer and other solid cancer tumors... view message ignore post recommend post

Group Home | Login if you want to post a message